New York State Common Retirement Fund decreased its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 1.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,168,549 shares of the company’s stock after selling 16,792 shares during the period. New York State Common Retirement Fund’s holdings in HCA Healthcare were worth $152,355,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of HCA. Benjamin F. Edwards & Company Inc. bought a new stake in HCA Healthcare during the fourth quarter valued at $25,000. Sontag Advisory LLC bought a new stake in HCA Healthcare during the fourth quarter valued at $26,000. Doyle Wealth Management bought a new stake in HCA Healthcare during the fourth quarter valued at $31,000. Trust Co. of Vermont lifted its stake in HCA Healthcare by 165.3% during the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock worth $41,000 after purchasing an additional 205 shares during the last quarter. Finally, Financial Gravity Wealth Inc. bought a new stake in HCA Healthcare during the first quarter worth about $47,000. 71.66% of the stock is owned by institutional investors.

In other news, insider Jon M. Foster sold 44,281 shares of the business’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $122.28, for a total value of $5,414,680.68. Following the completion of the sale, the insider now owns 96,052 shares of the company’s stock, valued at approximately $11,745,238.56. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 2.70% of the company’s stock.

NYSE HCA opened at $123.51 on Monday. HCA Healthcare Inc has a 1-year low of $101.30 and a 1-year high of $147.42. The stock has a market capitalization of $42.28 billion, a PE ratio of 12.64, a P/E/G ratio of 0.99 and a beta of 0.75.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, beating analysts’ consensus estimates of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The company had revenue of $12.52 billion during the quarter, compared to analyst estimates of $12.34 billion. During the same quarter in the previous year, the company posted $3.18 EPS. HCA Healthcare’s revenue for the quarter was up 9.6% on a year-over-year basis. On average, analysts expect that HCA Healthcare Inc will post 10.38 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend is Friday, May 31st. HCA Healthcare’s dividend payout ratio (DPR) is presently 16.38%.

Several equities research analysts have issued reports on HCA shares. Barclays dropped their price target on HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Raymond James raised HCA Healthcare from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $115.00 to $135.00 in a research note on Tuesday, April 23rd. Oppenheimer lifted their price target on HCA Healthcare from $142.00 to $150.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 30th. ValuEngine lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, March 6th. Finally, Deutsche Bank lifted their price target on HCA Healthcare from $160.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and nineteen have assigned a buy rating to the stock. HCA Healthcare currently has a consensus rating of “Buy” and an average target price of $149.41.

ILLEGAL ACTIVITY NOTICE: “HCA Healthcare Inc (HCA) Shares Sold by New York State Common Retirement Fund” was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.dailypolitical.com/2019/05/20/hca-healthcare-inc-hca-shares-sold-by-new-york-state-common-retirement-fund.html.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Story: Trading Options- What is a Strangle?

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.